Industry Updates

Anchen Pharmaceuticals, an Irvine niche generic drug developer, has been sold to Par Pharmaceutical Companies Inc. in Woodcliff Lake, N.J. for $410 million in cash. The deal is expected to close by the end of the year.

The Drug Control General of India’s recent decision to delegate more powers to the zonal offices of CDSCO will strengthen the national regulatory body and make help pharmaceutical industry across the country, especially the exporters and importers, according to PBN Prasad, Deputy DCGI, south zone, Chennai.

Granules India that engages in manufacturing and supplying active pharmaceutical ingredients will expand its API and pharmaceutical formulation intermediates to meet requirements of clients and augment market share of its best sellers.

The Prime Minister Syed Yusuf Raza Gillani directed the Cabinet Secretary to ensure uninterrupted provision of drugs and medicines to the patients all over the country and resolution of all outstanding issues of the Pharma industry.